🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ALK+ NSCLC best practices from Vincent Lam With 4 highly active TKIs available, we are moving toward ⬆️ precision 🎯to choose b/t them 1L and select for treatment intensification. Will we soon consider variants? 🧬 TLC Conference #TexasLung24 ALK Positive Johns Hopkins Thoracic Oncology

One of many great things about #TexasLung24, running into a stage 4 pt you hadn’t seen since moving from Texas yrs ago! What a gift. (posted w permission). #medicineisthebestjob TLC Conference

Outstanding work Dr. Michael Conroy 🇮🇪 awarded an ASCO Conquer Cancer, the ASCO Foundation Young Investigator Award for his study of an ALK-directed vaccine w Dr. Vincent Lam . Johns Hopkins Thoracic Oncology is on a roll, 7 ASCO YIAs in recent yrs! conferences.asco.org/am/conquer-can…

Cool stuff from Monte Winslow's Lab further suggesting that variant 3 is more oncogenic; perhaps other 'short' EML4-ALK fusions too. Also, tumor suppressors have variant-specific impact. On the road towards personalizing ALK therapy...

Such a treat to kick off Lung Cancer Awareness Month spinning as part of #SweatForBreath, an inspiring effort by David Cornbrooks to raise awareness and funding for ALK+ research. Humbled to be part of this tribe! #LCAM ALK Positive Johns Hopkins Thoracic Oncology every.org/the-sweat-for-…

Honored to be part of this #radicalcollaboration to advance cures in ALK+ and other lung cancers. Let's go!! Break Through Cancer ALK Positive Johns Hopkins Kimmel Cancer Center

1/ JUST IN: an 8 year #kidneycancer journey now published in nature: “A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma”. A trial of #RCC vaccine, led together with first author David Braun Yale Cancer Center and #PatrickOtt #DerinKeskin